Skip to main content
. 2014 Jan 4;14:5. doi: 10.1186/1471-2407-14-5

Table 1.

Rash rating scales used in this investigation

Grade EGFR-Inhibitor induced rash scale CTCAE Assessment scale
0
No rash
No rash
1
Isolated pustule or erythematous patch < 1 cm in diameter, on either face/head/neck or chest/back
Macular or papular eruption or erythema without associated symptoms
2
More than one erythematous patch or erythema and telangiectasia on either face/head/neck or chest/back
Macular or papular eruption or erythema with pruritus or other associated symptoms; localized desquamation or other lesions covering < 50% of body surface area
3
More than one pustule or papules on either face/head/neck or chest/back with no associated erythema or telangiectasia
Severe, generalized erythroderma or macular, papular or vesicular eruption; desquamation covering ≥ 50% body surface area
4
Both erythema/telangiectasia and pustules/papules limited to either face/head/neck or chest/back
Generalized exfoliative, ulcerative, or bullous dermatitis
5 Pustules or papules and erythema/telangiectasia present on both the face/head/neck region and the chest/back Death